Continue fostering our Great Place to Work® culture Strategic ObjectivesStrategic Objectives Long Term Growth Rates Growth DriversGrowth Drivers $340 $455 $790 $1,135 $51 $84 $212 $645 $108 $113 $231 $230 $265 $358 $726 $725 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable GrowthProfitable Growth Great Place to WorkGreat Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards ESG Ratings Performance 1 87th 94th percentile 5 Avient CDP Score: A- M AY 7 , 2024 W EB CAS T P RE SE N TATI O N 7 REGIONAL DEMAND TRENDS-TOTAL COMPANY Q 1 S A L E S V S P Y ( E X C L U D I N G F X ) 7 +2% -6% Flat +2% Avient ex. Q1 2023 (TOTAL COMPANY) $846 $829 $134 $143 17.3% (in millions) $0.63 $0.76 (in millions) + 7% + 21% Sales Adjusted EBITDA Adjusted EPS 9 - 2% 15.8% +150 bps Q1 2024 SEGMENT PERFORMANCE (COLOR, ADDITIVES & INKS) $537 $515 $91 $97 18.8% (in millions) (in millions) + 7% 10 - 4% 17.0% +180 bps • Year over year demand continues to improve for the segment but slowly due to continued weakness in Europe • Raw material deflation & cost reduction actions primary drivers of adjusted EBITDA growth and margin expansion of +180 bps vs Q1 2023 Q1 2024 SEGMENT PERFORMANCE (SPECIALTY ENGINEERED MATERIALS) $310 $314 $64 $73 23.2% (in millions) (in millions) + 14% 11 + 1% 20.8% +240 bps • Sales growth in defense end market offset by weaker demand in telecommunications end market • Raw material deflation and favorable mix impact from defense sales primary drivers of adjusted EBITDA growth and margin expansion of +240 bps vs Q1 2023 Q1 EBITDA BRIDGE (TOTAL COMPANY) 12 $ millions CAI: Price / Mix (1) Deflation 16 SEM: Price / Mix 4 Deflation 7 Net Price Benefit 26 Wage/Other Inflation (9) FX (2) Q1 2024 $143 Adjusted EBITDA Q1 2023 $ 134 Demand (6) • Positive net price benefit: o Favorable raw material deflation in both segments • Wage and other inflation more than offset cost reductions/synergies 2024 G U IDA N CE FY 2024 GUIDANCE Original Revised Adjusted EBITDA $505 to $535 million $510 to $535 million Adjusted EPS $2.40 to $2.65 $2.50 to $2.65 Interest Expense $105 to $110 million $105 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures ~$140 million ~$140 million 14 Q2 2024: Adjusted EPS of $0.71 CE O “TO P O F M IN D ” FO CU S ARE A S AREAS OF FOCUS 16 +7% Drive Profitable Organic Top-Line Growth with Margin Expansion Amplify Innovation Build Leadership & Talent Pipeline AP P EN D IX 19 Performance Additives 15% Pigments TiO2 Dyestuffs Polyethylene 10%Nylon Polypropylene Styrenic Block Copolymer Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 19% 23%Industrial Building and END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) 21 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 B ILL ION 34% 37% 21% END MARKET REGION 22 34% 21% 15% Building & 1% Energy COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 B ILL ION 52% 35% 23 6%Industrial 12% 10% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 26% Building & 6% 2% Defense 1% (18% of sales) 2023 AVIENT REGIONAL SALES 25% Building & (36% of sales)Transportation 22% Building & 12% 6% US & Canada (41% of sales) 59% 22% Building & LATAM (5% of sales) 24 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Medical textile manufacturer LEARN MORE MEDICAL TEXTILE MANUFACTURER S U R G I C A L D R A P E S & G O W N S • Pre-tested for ISO 10993 biocompatibility standard • Available in standard blue or other customized colors • Compatible with ETO sterilization • Suitable for use in non-woven SMS spunbond layer • Offered standard blue and custom colors such as green • Pre-tested raw materials for biocompatibility ISO10993 standard • Manufactured under ISO 13485 certified medical sites with change control in place MevopurTM Healthcare Colorants and Formulations KEY REQUIREMENTS WHY AVIENT?

SAFETY EQUIPMENT MANUFACTURER M I L I T A R Y H E L M E T P A R T S • High impact resistance • RAL 6031 – military green color • High molecular weight • Met impact resistance requirements for military helmets • Delivered strong collaboration with Avient Design team and service • Provided specific RAL color matching for military application Bergamid™ Polymer Formulations KEY REQUIREMENTS WHY AVIENT?

We are Avient. 6 BETTER TOGETHER: POLYONE AND CLARIANT MASTERBATCH Key Financial Data (1) 2021E Sales $4.6 - $4.7 billion 2021E EBITDA $580 million 2021E Free Cash Flow $280 million 87% of EBITDA from specialty applications (1) As of July 30, 2021 webcast Synergies ($ millions) Three-Year Estimate Administrative $ 20 Sourcing 30 Operational 25 Total Synergies $ 75 7 CLARIANT COST SYNERGIES • On-track to realize $45 million of expected synergies in 2021 – up from previous estimate of $35 million • Relentless focus on guiding principles for acquisition integration: safety first, employee collaboration and exceeding customer expectations • Future revenue synergies in excess of $50 million by 2025 are not part of these estimates and represent additional growth over the long term 8 • Barrier technology • Functional additives • Processing aids • Flame retardants • Light-weighting additives Complementary Technologies • Clariant’s approved formulations and certified facilities • Legacy PolyOne’s leading share in distribution channels Healthcare Solutions • Clariant’s position in SE Asia, Latin America, Germany & Italy • Legacy PolyOne’s position in U.S., Canada and China Regional Strengths • Solutions with Avient’s engineered materials customers • Avient’s distribution channels Segment Cross-selling COMPLEMENTARY TECHNOLOGIES AND CUSTOMERS DRIVE REVENUE SYNERGIES Revenue synergy opportunities in excess of $50MM by 2025 The complementary aspects of our combined businesses are unquestionable. ColorWorks innovation centers are specially designed to foster imagination and enable creative exploration of innovative solutions • Focus on customers’ sustainability initiatives through recyclability and post-consumer recycled materials for packaging applications • Supports 8-12% long-term revenue growth expectations across our sustainable solutions portfolio 14 2020 Pro forma $870 $69 Sustainable Solutions 66 37% 26 Healthcare 29 20% 7 Composites 12 36% 6 Growth in Asia / LATAM 47 39% 11 Other 190 48% 22 Sub-total $1,214 40% $141 COVID Response Applications (15) (8) FX Impact 36 4 Synergies 11 Incentives, Travel, Other Employee Costs (26) 2021 Actual $1,235 42% $122 Q2 2021 ORGANIC SALES AND OPERATING INCOME 15 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Sales Growth Rate Operating Income$ millions 16 Q2 2020PF Q2 2021 (2) Financial information is presented on a constant currency basis (1,2) (44% of total revenue) (56% of total revenue) Q2 END MARKET SALES PERFORMANCE +26% +38% +46% +103% +51% +9% +7% +67% Energy Telecom Building & Transportation Industrial Healthcare Packaging Consumer Q2 YEAR-OVER-YEAR EBITDA BRIDGE Q2 2020 Pro forma $ 106 Demand 69 17 EBITDA$ millions • Demand impact driven by growth in sustainable solutions and consumer products • Price increases more than offset raw material and supply chain impacts (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition CAI: Price / Mix 40 Inflation (32) SEM: Price / Mix 23 Inflation (18) Distribution: Price / Mix 81 Inflation (77) Net Price Benefit 17 Supply Chain Disruptions (14) COVID Response Applications (8) Synergies 11 Incentives, Travel, FX, Other (22) Q2 2021 Actual $ 159 Q1 2021 Actual $ 161 CAI: Price / Mix 32 Inflation (22) SEM: Price / Mix 15 Inflation (9) Distribution: Price / Mix 50 Inflation (48) Net Price Benefit 18 Supply Chain Disruptions (12) Demand / Seasonality (6) Other (2) Q2 2021 Actual $ 15918 EBITDA$ millions • Price increases more than offset raw material and freight inflation impacts • Demand impact driven by Q2 seasonality for the business Q1 TO Q2 SEQUENTIAL EBITDA BRIDGE Q 3 AN D FU LL Y EA R 2021 O U TLO O K $74 $98 $0.46 $0.68 ORGANIC GROWTH PROJECTIONS – Q3 20 Sales Adjusted Operating Income $925 $1,150 + 24% + 32% + 48% FULL YEAR GUIDANCE INCREASED 21 Sales Adj. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 29 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Other 2 2 2 2 3 3 3 4 3 4 4 5 5 5 5 5 6 7 27 e nt e nt ( xc l.

TPE GREEN STREAKER X HC 239776#SR-21260-7 Grey Conc 4% PX-C-116 GREEN MATTE

TP GREEN 382C GREEN 348C V2 X NM-15321-001-7 Natural

GREEN 334C X ET-6890-001-7 Natural WO LIME GREEN

GREEN GREEN PALE BLUE 2.5 PB 7/8 ABS

GREEN GLOW TPE PC DARK BROWN Q520-7-3 POISON GREEN 33C V4

GREEN 356C VEIN NEUTRAL 7 PP GREEN